Peste 4 milioane de titluri în engleză și alte limbi! Descoperă-ți noua poveste astăzi!

Muscular Dystrophy

Name: Muscular Dystrophy
Brand: Humana Press Inc.
SKU: 9780896036956
Price: 891.68 RON
Availability: InStock

Methods and Protocols

Autor: Katherine Bushby, Louise V.B. Anderson

Limbă:

Legare: Copertă tare

Editura: Humana Press Inc.

Disponibilitate: În depozitul extern în cantități mici

Expediem în 11-15 zile

891.68 lei

The term muscular dystrophy (MD) describes a group of primary genetic disorders of muscle that often...

Informații despre carte

Autor

Katherine Bushby, Louise V.B. Anderson

Limbă

engleză

Legare

Carte - Copertă tare

Publicat

2001

Pagini

458

EAN

9780896036956

ISBN

0896036952

Enbook ID

02716587

Editura

Humana Press Inc.

Greutate

858

Dimensiuni

237 x 161 x 37

Descriere completă

The term muscular dystrophy (MD) describes a group of primary genetic disorders of muscle that often have a distinctive and recognizable clinical p- notype, accompanied by characteristic, but frequently not pathognomonic, pathological features. Research into the molecular basis of the MDs by a c- bination of positional cloning and candidate gene analysis has provided the basis for a reclassification of these disorders, with genetic and protein data augmenting traditional clinically based nomenclature. These findings have brought insights into the molecular pathogenesis of MD, with an increasing number of potential pathways involved in arriving at a dystrophic phenotype. Some common themes can be recognized, however, including the involvement of five members of the dystrophin-associated complex (dystrophin and four sarcoglycans) in different types of MD, and the involvement of two nuclear envelope proteins in producing an Emery-Dreifuss MD phenotype. Other d- ease-associated genes appear to cause MD in a completely unrelated way, such as the involvement of calpain 3 in a form of limb-girdle muscular dystrophy. Section 1 of Muscular Dystrophy: Methods and Protocols reviews tra- tional strategies used to identify MDs. Meantime, techniques developed as a result of the research strategies described previously have become an integral part of the management of many patients with MD and their families, and these techniques are addressed in Sections 2 (DNA-based tests) and 3 (p- tein-based analyses). The continued effort to translate this enhanced und- standing into a molecular cure or treatment for MD is reviewed in Section 4.

Cele mai căutate

Categories

Authors

Publishers

Produse

Produse

Cele mai căutate

Categories

Authors

Publishers

Produse

Produse

Muscular Dystrophy

Methods and Protocols

Informații despre carte

Descriere completă

S-ar putea să te intereseze

Clienții care au cumpărat această carte au mai cumpărat și